ArticleScientific reports2026
MOV10, a novel immunotherapy and prognostic biomarker, contributes to glioma development by regulating autophagy.
Feiyu Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it